|
Volume 8, Review 59 |
September 1998 |
|
M. Aubier |
|
Opening remarks |
|
A. Papi, G. Caramori, L.M. Fabbri |
|
Current asthma therapies and issues in asthma management |
|
G.M. Cochrane |
|
Compliance in asthma |
|
S.D. Sullivan |
|
Economics of asthma and asthma treatments |
|
N.C. Barnes |
|
The role of leukotriene receptor antagonists in the management of asthma |
|
I.W. Rodger |
|
Leukotrienes, asthma, and the preclinical science of montelukast |
|
S. Lu, T.F. Reiss |
361 |
The dose selection of montelukast sodium (MF-0476) |
|
M. Aubier |
|
Closing remarks |